Preliminary Results 201 8
Paul Mines, CE O / Declan Brown, FD 01 April 201 9
Preliminary Results 201 8 Paul Mines, CE O / Declan Brown, FD 01 - - PowerPoint PPT Presentation
Preliminary Results 201 8 Paul Mines, CE O / Declan Brown, FD 01 April 201 9 Disclaimer The information contained in this presentation (the " Presentation ") has been prepared by and is the sole responsibility of the directors of
Paul Mines, CE O / Declan Brown, FD 01 April 201 9
Disclaimer
The information contained in this presentation (the "Presentation") has been prepared by and is the sole responsibility of the directors of Biome Technologies PLC (the "Company"). The Presentation and any further confidential information made available to any recipient, either verbally or in writing, must be held in complete confidence and documents containing such information may not be reproduced, used or disclosed without the prior written consent of the Company. The Presentation shall not be copied, reproduced
indirectly) to, and should not be acted upon by any class of person other than (i) qualified investors (within the meaning of the Prospectus Directive 2003/ 71 / EC) and (ii) investment professionals falling within Article 19(5) and high net worth companies falling within Article 49(2) respectively of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (or persons to whom it may otherwise be lawfully communicated) and may only be supplied, if permitted by applicable law, outside the United Kingdom to professionals or institutions whose ordinary business involves them engaging in investment activities (together "Relevant Persons"). Persons who are not Relevant Persons should not attend the Presentation or rely on or act upon the matters communicated at the Presentation. The Presentation does not constitute a prospectus relating to the Company; it has not been approved by the Financial Conduct Authority, nor does it constitute or form part of any
nor shall it nor any part of it nor the fact of its distribution form the basis of, or be relied on in connection with, any contract or investment decision in relation thereto. No reliance may be placed for any purpose whatsoever on the information contained in the Presentation or any assumptions made as to its completeness. The information contained in the Presentation, which has not been independently verified, is for background purposes only and is subject to verification, updating, revision and amendment and completion without notice. This Presentation does not purport to be all-inclusive or to contain all the information that an investor may desire to have in evaluating whether or not to make an investment in the Company. Certain statements in the Presentation are forward-looking statements, and the Presentation itself has been based upon a number of assumptions, forecasts and projections which by their nature are forward looking. Forward-looking statements are typically identified by the use of forward-looking terminology such as "believes", "expects", "may", "will", "could", "should", "intends", "estimates", "anticipate", "plans" or "assumes" or similar expressions, or by discussions of strategy that involve risk and uncertainties. By their nature, forward- looking statements, assumptions, forecasts and projections involve a number of risks and uncertainties, and in some cases are based on estimates and incomplete information, that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements or by the Presentation as a whole. These risks and uncertainties, and the impact they have on the assumptions, forecasts and projections contained in the Presentation, could adversely affect the outcome and financial effects of the plans and events described herein. No representation or warranty, express or implied, is made or given by or on behalf of the Company or its directors or any ot her person as to the accuracy, completeness or fairness
nothing in this paragraph shall exclude liability for any such representation or warranty made fraudulently. The distribution of this document in certain jurisdictions may be restricted by law and therefore persons into whose possession this document comes should inform themselves about and observe any such restrictions. Any such distribution could result in a violation of the law of such jurisdictions. Neither this document nor any copy of it may be taken or transmitted into the United States, Canada, Japan and the Republic of Ireland or distributed to the United States, Canada, Japan or the Republic of Ireland or to any national, citizen or resident thereof or any corporation, partnership or other entity created or organised under the laws thereof.
201 7 £m 201 8 £m Comment Group Revenue 6.2 8.9
+44% revenue growth
Biome Bioplastics S tanelco RF T echnologies (Gross Margin) 2.3 3.9 50% 1 .9 7.0 54%
Revenue loss in one USA application area, growth elsewhere Exceptional demand due to investment in Asian optical fibre market Margins change driven by product mix
Overheads Like-for-like operating profit / loss (3.0) (0.4) (4.1 ) 0.1 Supporting RF sales and Bioplastics activity First operating profit Like-for-like EBITDA Like-for-like operating profit / loss 0.1 (0.4) 0.6 0.1 First operating profit
Opening cash 2.3
EBITDA Capex/ R&D Working capital 0.6 (0.4) 0.1
Y ear end cash 31
/ 1 2/ 1 8
2.6
S ee Preliminary Results for further details
7
December 201 8: £2.6m
8
0m March 201 9
* Earnings before interest, depreciation, amortisation and share options charges. In addition the effect of a one off settlement income of £0.45m was removed from the result for 2016
(2,000) 2,000 4,000 6,000 8,000 10,000 2013 2014 2015 2016 2017 2018
£'000s Year
Key Financial Data 2013 to 2018
Turnover EBITDA *
In 201 8, the Board adopted stretching KPIs for the business through to end-2020 to continue its ambitious momentum:
revenue growth in the Bioplastics division. ❖ The Group exceeded this target although the target was not met in the Bioplastics division
5% of revenues by 2020. ❖ Not achieved as turnover dominated by the exceptional demand for fibre optic furnaces.
strategic objective cycle. ❖ The Group met this target in 2018 with £0.8m spent in 2018.
2, a focused bioplastics business.
renewable content.
rigid materials and non-woven filtration products.
market being explored,
multi-nationals.
0bn
(Source: Euromonitor)
0, end-customers are leading brands in the USA market
USA market (port folio also includes bags/ lids/outer packaging)
with further material replacement, new customers and new geographic markets
trategy to diversify the customer base - there are a number of projects which have the potential to substantially increase sales in 201 9.
➢ material for a rigid ring to the coffee market that is heat stable - advanced stage with revenues anticipated Q2 ➢ a novel material for a single serve nutrition pod ➢ disposable cutlery for the US market ➢ a plastic film-based product
UK Plastics Pact* - 2025 targets Promotional activity PR / Education
* Coalition of companies that account for some 80% of consumer packaging in the UK
Biotechnology.
biodegradable polyesters.
research and development aimed at scaling and commercialising these novel bio-based polyesters.
Spain.
scale-up of the processes and establishing the commercial viability of the novel polyesters.
in policy and legislation
much wider range of development projects than it has before, with a variety
from 201 9 to 2022
resources, including the recruitment of commercial and scientific staff
welding, heating and furnace technology.
8 exceptional demand for fibre-optic furnaces driven by adoption
the internet.
trong cash generation
and precious metal processing.
tanelco RF has repeating revenues from power generation, medical and general industrial markets, primarily in the UK.
applications.
level of support are key to the product offering.
8 not expected to be repeated in 201 9 but to be higher than 201 7
diversify the industrial port folio progress being made
8 the division successfully designed, built, and delivered a product to be used in the metal melting market. Further diversification in this thematic area is being pursued
tanelco RF is designing and developing products that will enable this expansion
increase in Bioplastics revenues over the year.
tanelco RF division 201 8 was an exceptional year with a record number of deliveries of optic fibre furnaces. There will be a period whilst these before they undertake significant further expansion. Therefore, revenues in 201 9 are anticipated to be at a lower level than the £7m achieved in 201 8 but higher than the £4m achieved in 201 7.
8 remain unchanged
for both divisions is in line with the expectations set out above.
and an emerging technology pipeline based on industrial biotechnology. With rapid changes in the public perception of oil-based market, this business represents an
position that can be further exploited as the technology is applied to new application areas.
6 and cash balances (£2.6m at December 201
8) gives the
Group good operational flexibility.
8 improves the growth potential of both businesses.
Address Biome T echnologies plc North Road Marchwood Southampton SO40 4BL
Call us +44 (0) 2380 867 1 00 Email us info@biometechnologiesplc.co.uk Website
ht tp:// www.thinkbioplastic.com /
Listed on the AIM market, the international market for growing companies trading on the London S tock Exchange, allowing both existing and new shareholders to participate in
Core strategy is to develop its bioplastics business
exploitation of higher value areas where the properties
most suitable and valued. Engaged with a variety of large-scale international customers and partners on a number of key commercial and development partnerships. Protects its existing intellectual property in a robust manner and protects new developments through patents and confidentiality. Driving an international expansion of activities and now operates in Europe, North America and Asia. Headquarters and R&D activity is based at Southampton in the UK. Robust ethical and governance policies and a Board commit ted to driving enhanced shareholder value.
John F S tanden Non-Executive Chairman Declan Brown Group Finance Director Paul R Mines Chief Executive Officer Michael Kayser Independent Non-Executive Director
Holder Shares % Mr V Pereira* 534,022 22.57% Mr JM Rushton-T urner 288,050 1 2.27% Miss G Pereira 79,286 3.35% Miss B Pereira 78,1 49 3.30% Holder Shares % Mr Paul Mines 26,525 1 .1 2% Mr John S tanden** 53,336 2.26% Mr Declan Brown 3,970 0.1 7% Mr Michael Kayser 4,071 0.1 7%
Principal shareholders Directors
82,41 6 held by his wife, Mrs G Pereira. **Mr John holding includes 1 3,250
28,836 held by Leapacross Ltd (a company controlled by John S tanden) and 11 ,250 held by his wife, Mrs K M S tanden.
currently at tract tax at 1 0% of any gains over the exercise price of £2.1 5 per share
0 December 201 8
prior to the vesting date, is required in order for the benefits of the LTIP to commence
6%
st vesting on 1
0 December resulted in 11 9,01 5 available for exercise shares (out of a maximum 306,1 76 shares under option under the scheme)